Publications by authors named "Euan A Stronach"

25Publications

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Authors:
Aline Talhouk Joshy George Chen Wang Timothy Budden Tuan Zea Tan Derek S Chiu Stefan Kommoss Huei San Leong Stephanie Chen Maria P Intermaggio Blake Gilks Tayyebeh M Nazeran Mila Volchek Wafaa Elatre Rex C Bentley Janine Senz Amy Lum Veronica Chow Hanwei Sudderuddin Robertson Mackenzie Samuel C Y Leong Geyi Liu Dustin Johnson Billy Chen Aocs Group Jennifer Alsop Susana N Banerjee Sabine Behrens Clara Bodelon Alison H Brand Louise Brinton Michael E Carney Yoke-Eng Chiew Kara L Cushing-Haugen Cezary Cybulski Darren Ennis Sian Fereday Renée T Fortner Jesús García-Donas Aleksandra Gentry-Maharaj Rosalind Glasspool Teodora Goranova Casey S Greene Paul Haluska Holly R Harris Joy Hendley Brenda Y Hernandez Esther Herpel Mercedes Jimenez-Linan Chloe Karpinskyj Scott H Kaufmann Gary L Keeney Catherine J Kennedy Martin Köbel Jennifer M Koziak Melissa C Larson Jenny Lester Liz-Anne Lewsley Jolanta Lissowska Jan Lubiński Hugh Luk Geoff Macintyre Sven Mahner Iain A McNeish Janusz Menkiszak Nikilyn Nevins Ana Osorio Oleg Oszurek José Palacios Samantha Hinsley Celeste L Pearce Malcolm C Pike Anna M Piskorz Isabelle Ray-Coquard Valerie Rhenius Cristina Rodriguez-Antona Raghwa Sharma Mark E Sherman Dilrini De Silva Naveena Singh Peter Sinn Dennis Slamon Honglin Song Helen Steed Euan A Stronach Pamela J Thompson Aleksandra Tołoczko Britton Trabert Nadia Traficante Chiu-Chen Tseng Martin Widschwendter Lynne R Wilkens Stacey J Winham Boris Winterhoff Alicia Beeghly-Fadiel Javier Benitez Andrew Berchuck James D Brenton Robert Brown Jenny Chang-Claude Georgia Chenevix-Trench Anna deFazio Peter A Fasching María J García Simon A Gayther Marc T Goodman Jacek Gronwald Michelle J Henderson Beth Y Karlan Linda E Kelemen Usha Menon Sandra Orsulic Paul D P Pharoah Nicolas Wentzensen Anna H Wu Joellen M Schildkraut Mary Anne Rossing Gottfried E Konecny David G Huntsman Ruby Yun-Ju Huang Ellen L Goode Susan J Ramus Jennifer A Doherty David D Bowtell Michael S Anglesio

Clin Cancer Res 2020 Oct 17;26(20):5411-5423. Epub 2020 Jun 17.

British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-0103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572656PMC
October 2020

CELLector: Genomics-Guided Selection of Cancer In Vitro Models.

Cell Syst 2020 May;10(5):424-432.e6

Open Targets, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK; Human Technopole, 20157, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cels.2020.04.007DOI Listing
May 2020

MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.

Endocr Relat Cancer 2016 09 27;23(9):711-26. Epub 2016 Jun 27.

Department of Surgery and CancerImperial College, Hammersmith Hospital Campus, London, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0044DOI Listing
September 2016

Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy.

Front Oncol 2015 26;5:240. Epub 2015 Oct 26.

Molecular Therapy Laboratory, Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620694PMC
November 2015

Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.

Front Oncol 2014 17;4:81. Epub 2014 Apr 17.

Molecular Therapeutics Laboratory, Ovarian Cancer Action Research Centre, Institute of Reproductive and Developmental Biology, Department of Cancer and Surgery , Imperial College London, London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029026PMC
June 2014

Opportunities for translation: targeting DNA repair pathways in pancreatic cancer.

Biochim Biophys Acta 2014 Aug 13;1846(1):45-54. Epub 2014 Apr 13.

Molecular Therapy Laboratory, Department of Cancer and Surgery, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0304419X140003
Publisher Site
http://dx.doi.org/10.1016/j.bbcan.2014.04.002DOI Listing
August 2014

Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.

Mod Pathol 2014 Mar 16;27(3):433-42. Epub 2013 Aug 16.

1] Department of Histopathology, Centre for Pathology, Imperial College London, Hammersmith Hospital, London, UK [2] Department of Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.130DOI Listing
March 2014

Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose- and 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer.

Mol Imaging Biol 2012 Dec;14(6):753-61

Comprehensive Cancer Imaging Centre, Department of Cancer & Surgery, Faculty of Medicine, Imperial College London, Hammersmith Hospital, 240 MRC Cyclotron Building, Du Cane Road, London, W12 0NN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-012-0554-2DOI Listing
December 2012

DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.

Neoplasia 2011 Nov;13(11):1069-80

Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223610PMC
http://dx.doi.org/10.1593/neo.111032DOI Listing
November 2011

HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

Cancer Res 2011 Jul 13;71(13):4412-22. Epub 2011 May 13.

Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, Edinburgh, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-4111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130134PMC
July 2011

Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression.

Cancer Res 2003 Dec;63(24):8648-55

Cancer Research UK, Edinburgh Oncology Unit, University of Edinburgh Cancer Research Centre, Edinburgh, Scotland, United Kingdom.

View Article

Download full-text PDF

Source
December 2003

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.

Nat Genet 2003 Jul;34(3):337-43

Cancer Research UK Edinburgh Oncology Unit, University of Edinburgh Cancer Research Centre, Crewe Road South, Edinburgh EH4 2XR, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng1183DOI Listing
July 2003